D.E. Shaw & Co’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-395
Closed -$231K 2750
2018
Q2
$231K Buy
+395
New +$231K ﹤0.01% 2399